Nanobiotix Asia Partner PharmaEngine Launches Clinical Trial in Head, Neck Cancers
PharmaEngine, the Asia-Pacific partner of Nanobiotix (Euronext:Nano), has dosed its first patient in a new Phase I/II trial in patients with head and neck cancers patients receiving radiotherapy plus chemotherapy…